Biodegradable nanoparticle flocculates for dry powder aerosol formulation

被引:42
作者
Shi, Lianjun [1 ]
Plumley, Carl J. [1 ]
Berkland, Cory [1 ]
机构
[1] Univ Kansas, Dept Pharmaceut Chem, Dept Chem & Petr Engn, Lawrence, KS 66047 USA
关键词
D O I
10.1021/la7020098
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Uncontrolled agglomeration presents a formidable encumbrance to nanoparticle formulation as a dry powder for inhalation therapy. Spray-drying and freeze-drying of nanosuspensions has demonstrated some success in creating dry powders composed of agglomerated nanoparticles with appropriate aerodynamic properties. These controlled drying processes, however, may require an undesirable amount of excipient to maintain an active therapeutic while generating dry powders and may not offer the desired control over agglomerate size and aerosolizability. As a potential alternative approach, a method for flocculating nanoparticles in solution followed by freeze-drying is reported. Biodegradable poly(DL-lactic-co-glycolic acid) nanoparticles were self-assembled into floes via electrostatic interactions between nanoparticles coated with oppositely charged polyelectrolytes. The size of the nanoparticle floes was readily Controlled by manipulating the mixing ratio of charged nanoparticles. Freeze-drying the flocculated nanoparticles produced dry powders exhibiting low density (similar to 0.1 g/cm(3)), a weblike morphology, and desirable aerodynamic properties suited for dry powder aerosols.
引用
收藏
页码:10897 / 10901
页数:5
相关论文
共 29 条
[1]   The Re-Emergence of Aerosol Gene Delivery: A Viable Approach to Lung Cancer Therapy [J].
Densmore, Charles L. .
CURRENT CANCER DRUG TARGETS, 2003, 3 (04) :275-286
[2]   Large porous particles for pulmonary drug delivery [J].
Edwards, DA ;
Hanes, J ;
Caponetti, G ;
Hrkach, J ;
BenJebria, A ;
Eskew, ML ;
Mintzes, J ;
Deaver, D ;
Lotan, N ;
Langer, R .
SCIENCE, 1997, 276 (5320) :1868-1871
[3]   New polymeric carriers for controlled drug delivery following inhalation or injection [J].
Fu, J ;
Fiegel, J ;
Krauland, E ;
Hanes, J .
BIOMATERIALS, 2002, 23 (22) :4425-4433
[4]   Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system [J].
Geller, DE ;
Rosenfeld, M ;
Waltz, DA ;
Wilmott, RW .
CHEST, 2003, 123 (01) :28-36
[5]  
GUATAM A, 2002, AM J RESP MED, V1, P35
[6]   In vivo lung deposition of hollow porous particles from a pressurized metered dose inhaler [J].
Hirst, PH ;
Pitcairn, GR ;
Weers, JG ;
Tarara, TE ;
Clark, AR ;
Dellamary, LA ;
Hall, G ;
Shorr, J ;
Newman, SP .
PHARMACEUTICAL RESEARCH, 2002, 19 (03) :258-264
[7]   In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis [J].
Hoeben, BJ ;
Burgess, DS ;
McConville, JT ;
Najvar, LK ;
Talbert, RL ;
Peters, JI ;
Wiederhold, NP ;
Frei, BL ;
Graybill, JR ;
Bocanegra, R ;
Overhoff, KA ;
Sinswat, P ;
Johnston, KP ;
Williams, RO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) :1552-1554
[8]   Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease [J].
John, AE ;
Lukacs, NW ;
Berlin, AA ;
Palecanda, A ;
Bargatze, RF ;
Stoolman, LM ;
Nagy, JO .
FASEB JOURNAL, 2003, 17 (13) :2296-+
[9]   Biodegradable microspheres with enhanced capacity for covalently bound surface ligands [J].
Keegan, ME ;
Falcone, JL ;
Leung, TC ;
Saltzman, WM .
MACROMOLECULES, 2004, 37 (26) :9779-9784
[10]  
Kumar Mukesh, 2003, Genet Vaccines Ther, V1, P3, DOI 10.1186/1479-0556-1-3